In contrast, the down-regulation of ESR1 is suggestive of better OS in acute myeloid leukemia (LAML), brain lower grade glioma (LGG), lung squamous cell carcinoma (LUSC) and stomach adenocarcinoma (STAD). The gene discussed is ESR1; the disease is acute myeloid leukemia.